Lauren Schaff, MD
Neurologist & Neuro-Oncologist
My Role at MSKWe post reviews for MSK healthcare providers who have at least 30 patient experience surveys completed. If you do not see reviews for a provider, it may be because they do not yet have enough survey responses, or the provider may not be part of the group of healthcare providers included in the survey.
Only outpatient providers are included in the survey. Healthcare providers who only work in the hospital or in urgent care are not included in the survey. Pathologists or researchers who do not provide direct care to patients do not have reviews.
About Me
- Associate Director, Neuro-Oncology Fellowship Program
I am a neuro-oncologist who specializes in treating primary brain tumors, such as glioma (including glioblastoma, astrocytoma, oligodendroglioma, ependymoma) and central nervous system lymphoma. I see patients at Memorial Sloan Kettering in Manhattan and at MSK Bergen, in New Jersey.
Read more
I work with a specialized team of physicians, nurses, research, and administrative staff to stay on the cutting edge of cancer therapeutics. At the same time, I am committed to supporting my patients and their caregivers through this challenging period of their lives. My goal is to help patients continue to enjoy the things they love to do while providing them with the reassurance that they have a team of experts working on their side.
A neurologist is a doctor with special training in the brain, spinal cord, nerves, and muscles.
A neuro-oncologist is a doctor with special training in cancers that affect the brain, spinal cord, peripheral nerves, and muscles. This includes brain tumors and central nervous system tumors.
My Specialties
- Neuro-Oncology
- Adult Primary Brain Tumors
- Gliomas
- Central Nervous System Lymphoma
Education
- MD, Vanderbilt University
Residencies
- Neurology – New York-Presbyterian/Columbia University Medical Center
Awards and Honors
- Annual Meeting Scholarship Recipient, American Academy of Neurology (2015)
Fellowships
- Neuro-Oncology – Memorial Sloan Kettering Cancer Center
Board Certifications
- Psychiatry & Neurology
- Neuro-Oncology
Insurance Information
Understanding your insurance options is an important part of managing your cancer care. We have relationships with many common healthcare providers and plans.
In Network Coverage Type
PPO
In Network Coverage Type
PPO, POS, EPO, HMO
In Network Coverage Type
PPO, HMO, DSN
In Network Coverage Type
HMO, PPO
In Network Coverage Type
HMO, EPO PPO, POS
In Network Coverage Type
PPO, POS, EPO, HMO
Offers a qualified health plan from the Health Insurance Marketplace. Call Emblem to learn more.
In Network Coverage Type
PPO, HMO
In Network Coverage Type
PPO
In Network Coverage Type
HMO, EPO
Offers a qualified health plan from the Health Insurance Marketplace. Call Fidelis to learn more.
In Network Coverage Type
EPO, HMO, PPO, POS
Offers a qualified health plan from the Health Insurance Marketplace. Call Healthfirst to learn more.
In Network Coverage Type
HMO
In Network Coverage Type
PPO
In Network Coverage Type
EPO
In Network Coverage Type
EPO
In Network Coverage Type
Federal Government
In Network Coverage Type
PPO, POS, EPO, HMO
In Network Coverage Type
State Government
Don't see your carrier or plan? We can help you understand your coverage.
If you don't have health insurance or are worried that your care may not be fully covered, our financial assistance programs may be able to help.
If you have questions about insurance, call us at 646-497-9176.
Make an Appointment
Contact and Location
Dr. Schaff sees patients at two locations.
Looking to see a doctor at a different location? See all MSK locations.
Colleagues
Doctors at Memorial Sloan Kettering work as teams, with specialists from all different areas. This allows us to consider all your needs together, and to give you the best possible care.
Clinical Trials
- Clinical Trials Investigated by Dr. Schaff
- A Phase 1 Study of Debio 0123 With Temozolomide for People With Glioblastoma
- A Phase 1/2 Study of AZD9574 Alone and With Other Anti-Cancer Drugs in People with Glioma
- A Phase 2 Study of Pembrolizumab Immunotherapy, Olaparib, and Temozolomide in People With Glioblastoma
- A Phase II Study of Pembrolizumab Immunotherapy, Olaparib, and Temozolomide in People with Recurrent Glioma
Read more
- A Pilot Study of Glucarpidase in Patients with Central Nervous System Lymphoma
- A Study of L19TNF Plus Lomustine in People With Brain Cancer
- Clinical Trials Co-Investigated by Dr. Schaff
- A Clinical Trial to Evaluate Multiple Treatment Regimens for Newly Diagnosed Recurrent Glioblastoma (GBM AGILE)
- A Phase 1 Study of DZD8586 in People With B-Cell Non-Hodgkin Lymphoma
- A Phase I Study of Vorasidenib with Pembrolizumab Immunotherapy for Recurrent or Persistent IDH-1 Mutant Astrocytomas
- A Phase I/II Study of Ibrutinib in Patients with Recurrent or Persistent Central Nervous System (CNS) Lymphoma
- A Phase II Study of Tirabrutinib to Treat Primary Central Nervous System Lymphoma
- A Study Exploring New Therapies for Newly Diagnosed Glioblastoma
- A Study of CA-4948 in Patients with Recurrent or Persistent Non-Hodgkin Lymphoma
- Access to Vorasidenib for the Treatment of Glioma
Memorial Sloan Kettering's doctors and scientists are constantly developing new treatments for cancer. MSK is typically running hundreds of clinical trials at a given time.
You may be able to participate in a clinical trial even if you are new to MSK. Search our online directory to find trial information and see more about who can participate.
Search clinical trialsResearch and Publications
Visit PubMed for a full listing of Dr. Schaff’s journal articles. Pubmed is an online index of research papers and other articles from the US National Library of Medicine and the National Institutes of Health.
See all on PubMedPatient Reviews
Your trust is our main concern
We strive to keep reviews trustworthy, honest and fair. Learn more about our patient experience reviews.
Disclosures
Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.
MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.
Lauren Schaff discloses the following relationships and financial interests:
-
BTG International
Intellectual Property Rights -
BTG Pharmaceuticals
Professional Services and Activities -
Ono Pharma
Professional Services and Activities
-
Resonance, Inc.
Professional Services and Activities -
Servier
Professional Services and Activities
If you’re a patient at MSK and would like more information about your doctor’s external relationships, please talk with your doctor.
The information published here is a complement to other publicly reported data and is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.
This page and data include information for a specific MSK annual disclosure period (January 1, 2023 through disclosure submission in spring 2024). This data reflects interests that may or may not still exist. This data is updated annually.
Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at [email protected].